Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
MDM2- and FLT3-inhibitors in the treatment of FLT3-ITD acute myeloid leukemia, specificity and efficacy of NVP-HDM201 and midostaurin.
Haematologica. 2018 Nov;103(11):1862-1872. doi: 10.3324/haematol.2018.191650. Epub 2018 Jul 5.
Haematologica. 2018.
PMID: 29976747
Free PMC article.
The Cellular p53 Inhibitor MDM2 and the Growth Factor Receptor FLT3 as Biomarkers for Treatment Responses to the MDM2-Inhibitor Idasanutlin and the MEK1 Inhibitor Cobimetinib in Acute Myeloid Leukemia.
Seipel K, Marques MAT, Sidler C, Mueller BU, Pabst T.
Seipel K, et al. Among authors: marques mat.
Cancers (Basel). 2018 May 31;10(6):170. doi: 10.3390/cancers10060170.
Cancers (Basel). 2018.
PMID: 29857559
Free PMC article.
Item in Clipboard
Cite
Cite